The global shortage in the medical isotope molybdenum-99 that started a year ago has only gotten "a lot worse," said Robert Atcher, former SNM president. Canadian regulators and lawmakers have failed to fulfill their commitment of providing the U.S. with sufficient isotopes, and European reactors, while promising, present transportation challenges, Atcher said. The U.S. needs to call on Canada to honor its previous commitments and to allot more funding for a new isotope production system in the country, Atcher said.

Related Summaries